Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BLU-222 |
| Trade Name | |
| Synonyms | BLU 222|BLU222|Certociclib |
| Drug Descriptions |
BLU-222 selectively inhibits CDK2, potentially leading to inhibition of cell growth and decreased tumor growth (PMID: 39945650). |
| DrugClasses | CDK2 Inhibitor 32 |
| CAS Registry Number | 2888704-84-3 |
| NCIT ID | C188045 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BLU-222 | BLU-222 | 0 | 0 |
| BLU-222 + Carboplatin | BLU-222 Carboplatin | 0 | 1 |
| BLU-222 + Fulvestrant | BLU-222 Fulvestrant | 0 | 1 |
| BLU-222 + Fulvestrant + Ribociclib | BLU-222 Fulvestrant Ribociclib | 0 | 1 |